⏳
Case-based MCQ | #Case_371 | #answer
〰〰〰〰〰〰〰〰〰〰〰〰〰〰
✅
A
🔎 Explanation
This patient has characteristic features of
lower urinary tract symptoms (LUTS). LUTS can
present with voiding symptoms (bladder emptying) such as weak urine stream, hesitancy (difficulty starting urination) or intermittency of follow, or with storage (bladder filling) symptoms such as urgency, daytime frequency and nocturia.
Predominance of storage symptoms requires exclusion of conditions such as primary bladder pathology/malignancy, diabetes mellitus, and medications with diuretic effects. Where nocturia is the presenting symptom, nocturnal polyuria should be excluded too.
Based on the international guidelines, it is important to determine the severity of LUTS and to identify the complicating factors such as urinary retention, macroscopic hematuria, urinary tract infections or a personal or family history of prostate cancer.
For every patient presenting with LUTS, initial investigations should be considered to exclude
sinister causes LUTS or complications associated with bladder outflow obstruction. These investigations include:
•
Urinalysis - excluding hematuria, proteinuria, or pyuria - follow up with urine culture is required if there is abnormality on urinalysis
•
Serum creatinine and estimated glomerular filtration rate (eGFR) - this test is required for exclusion of renal injury from primary renal dysfunction or high-pressure bladder outflow obstruction.
•
Urinary tract ultrasound - assessment of prostate volume, bladder wall and residual urine
and exclusion of hydronephrosis
•
Prostate specific antigen to exclude prostate cancer - most guidelines recommend the use of serum PSA only if prostate cancer diagnosis will influence management or if the test will assist in decision making
Urinary symptoms of this man and the presence of an
enlarged prostate on DRE make benign prostatic hyperplasia
(BPH) the most likely diagnosis. Additionally, the dull mas over the suprapubic area is very likely to be a
distended bladder due to urinary
outflow obstruction caused by the enlarged prostate. In this situation and of the options, a
serum creatinine level [and calculation of the estimated glomerular filtration rate (eGFR)] would be the most important next step to exclude renal injury caused by the obstruction.
If an option, transabdominal ultrasound scan of the bladder was another important test to
consider first to assess the residual volume, prostate size and other possible urinary tract
anomalies.
⚠ (Option B) While transabdominal ultrasound is a very important investigation for this patient, tansrectal ultrasound is not necessary at this stage. Flowever, it might be applied in patients who are suspected of having prostate cancer for further assessment and as a guide for biopsy.
⚠ (Option C) CT scan is not routinely recommended for patients with LUTS, unless complicating features are suspected. An example could be for staging in a patient with bladder or prostate cancer as the etiologic cause of LUTS.
⚠ (Option D) As mentioned earlier, PSA is among the investigations for male patients with LUTS to exclude for prostate cancer; however, assessment of renal function takes precedence over PSA in this patient.
⚠ (Option E) Urine cytology is a test considered for patients with suspected urothelial carcinoma such as those with hematuria who have risk factors like history of smoking or exposure to certain chemicals. It is not a routine test for patients with LUTS unless there are alarming features